A59V (p.Ala59Val) variant of SOST (Sclerostin)

A59V (p.Ala59Val) in SOST (Sclerostin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.75 / 1. The record also includes population frequency data and structural context.

A59V (p.Ala59Val) variant details